{"title": "Inmunidad senescente en ancianos y respuestas a vacunas (SILVER)", "author": "Spyros Kalams", "url": "https://ichgcp.net/es/clinical-trials-registry/NCT04077424", "hostname": "ichgcp.net", "description": "Estudiar los efectos de la edad en la respuesta del sistema inmunitario a la vacuna contra la gripe y estudiar la conexi\u00f3n entre el sistema inmunitario y los ca.... Registro de ensayos cl\u00ednicos. ICH GCP.", "sitename": "ichgcp.net", "date": "2019-08-30", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Inmunidad senescente en ancianos y respuestas a vacunas (SILVER)\n[Vanderbilt University Medical Center](https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Vanderbilt%20University%20Medical%20Center)\nAn\u00e1lisis molecular de c\u00e9lulas individuales de las respuestas de c\u00e9lulas T inducidas por la vacuna contra la influenza en adultos de 65 a\u00f1os de edad o mayores\nDescripci\u00f3n general del estudio\nEstado\nCondiciones\nIntervenci\u00f3n / Tratamiento\nTipo de estudio\nInscripci\u00f3n (Actual)\nFase\n- Fase 4\nContactos y Ubicaciones\nUbicaciones de estudio\n-\nEstados Unidos\n-\nTennessee\n-\nNashville, Tennessee, Estados Unidos, 37211\n- Vanderbilt University Medical Center\n-\n-\nCriterios de participaci\u00f3n\nCriterio de elegibilidad\nEdades elegibles para estudiar\nAcepta Voluntarios Saludables\nG\u00e9neros elegibles para el estudio\nDescripci\u00f3n\nCriterios de inclusi\u00f3n:\n- Edad de 65 a\u00f1os y m\u00e1s\n- Vida independiente (incluida la vida asistida)\nCriterio de exclusi\u00f3n:\n- No se puede entender el consentimiento o el estudio.\n- Al\u00e9rgico a cualquier componente de la vacuna, excepto los huevos.\n- Historia de Guillain-Barr\u00e9.\n- Residir en un centro de atenci\u00f3n a largo plazo, como un hogar de ancianos.\nPlan de estudios\n\u00bfC\u00f3mo est\u00e1 dise\u00f1ado el estudio?\nDetalles de dise\u00f1o\n- Prop\u00f3sito principal: Ciencia b\u00e1sica\n- Asignaci\u00f3n: Aleatorizado\n- Modelo Intervencionista: Asignaci\u00f3n paralela\n- Enmascaramiento: Doble\nArmas e Intervenciones\n|\n|\nGrupo de participantes/brazo\n|\n|\nIntervenci\u00f3n / Tratamiento\n|\n|\nComparador activo: Fluzone-dosis alta\nVacuna antigripal inactivada de dosis alta aprobada por la FDA (HD-Fluzone)\n|\n|\nVacunaci\u00f3n contra la influenza estacional con vacunas aprobadas por la FDA para este grupo de edad.\nOtros nombres:\n|\n|\nComparador activo: Fluad\nVacuna antigripal inactivada con adyuvante (MF59) (Fluad)\n|\n|\nVacuna antigripal inactivada con adyuvante (MF59)\nOtros nombres:\n|\n|\nComparador activo: Vacuna de hemaglutinina recombinante (Flublok)\nVacuna de hemaglutinina recombinante\n|\n|\nVacuna de hemaglutinina recombinante\nOtros nombres:\n\u00bfQu\u00e9 mide el estudio?\nMedidas de resultado primarias\n|\n|\nMedida de resultado\n|\n|\nMedida Descripci\u00f3n\n|\n|\nPeriodo de tiempo\n|\n|\nT\u00edtulos del ensayo de inhibici\u00f3n del ant\u00edgeno de hemaglutinina al inicio\nPeriodo de tiempo: L\u00ednea de base L\u00ednea de base\n|\n|\nSerie de diluci\u00f3n doble de suero y medici\u00f3n del t\u00edtulo que inhibe la hemaglutinaci\u00f3n.\nSe midieron los t\u00edtulos para cada uno de los 4 ant\u00edgenos de la vacuna (A/Brisbane/2018 (H1N1), A/Kansas/2017 (H3N2), B/Colorado/2017 (Vic), B/Phuket/2013 (Yam))\n|\n|\nL\u00ednea de base L\u00ednea de base\n|\n|\nT\u00edtulos del ensayo de inhibici\u00f3n del ant\u00edgeno de hemaglutinina en el d\u00eda 28\nPeriodo de tiempo: D\u00eda 28 L\u00ednea base\n|\n|\nSerie de diluci\u00f3n doble de suero y medici\u00f3n del t\u00edtulo que inhibe la hemaglutinaci\u00f3n.\nSe midieron los t\u00edtulos para cada uno de los 4 ant\u00edgenos de la vacuna (A/Brisbane/2018 (H1N1), A/Kansas/2017 (H3N2), B/Colorado/2017 (Vic), B/Phuket/2013 (Yam))\n|\n|\nD\u00eda 28 L\u00ednea base\nColaboradores e Investigadores\nPatrocinador\nInvestigadores\n- Investigador principal: Spyros Kalams, Vanderbilt University Medical Center\nFechas de registro del estudio\nFechas importantes del estudio\nInicio del estudio (Actual)\nFinalizaci\u00f3n primaria (Actual)\nFinalizaci\u00f3n del estudio (Actual)\nFechas de registro del estudio\nEnviado por primera vez\nPrimero enviado que cumpli\u00f3 con los criterios de control de calidad\nPublicado por primera vez (Actual)\nActualizaciones de registros de estudio\n\u00daltima actualizaci\u00f3n publicada (Actual)\n\u00daltima actualizaci\u00f3n enviada que cumpli\u00f3 con los criterios de control de calidad\n\u00daltima verificaci\u00f3n\nM\u00e1s informaci\u00f3n\nT\u00e9rminos relacionados con este estudio\nPalabras clave\nT\u00e9rminos MeSH relevantes adicionales\nOtros n\u00fameros de identificaci\u00f3n del estudio\n- single cell\nPlan de datos de participantes individuales (IPD)\n\u00bfPlanea compartir datos de participantes individuales (IPD)?\nDescripci\u00f3n del plan IPD\nCriterios de acceso compartido de IPD\nInformaci\u00f3n sobre medicamentos y dispositivos, documentos del estudio\nEstudia un producto farmac\u00e9utico regulado por la FDA de EE. UU.\nEstudia un producto de dispositivo regulado por la FDA de EE. UU.\nEsta informaci\u00f3n se obtuvo directamente del sitio web\n[clinicaltrials.gov](https://clinicaltrials.gov) sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comun\u00edquese con [register@clinicaltrials.gov](mailto:register@clinicaltrials.gov). Tan pronto como se implemente un cambio en [clinicaltrials.gov](https://clinicaltrials.gov), tambi\u00e9n se actualizar\u00e1 autom\u00e1ticamente en nuestro sitio web. .\nEnsayos cl\u00ednicos sobre Vacuna contra la gripe\n-\nNCT05996549ReclutamientoVacuna contra la influenza | Vacunaci\u00f3n | Rentabilidad\n-\nNCT05869968ReclutamientoLesiones de la m\u00e9dula espinal | Vacuna para el COVID-19 | Lesi\u00f3n traum\u00e1tica de la m\u00e9dula espinal | Controles saludables | Vacuna contra la gripe\n-\nNCT05518500Reclutamiento\n[Un an\u00e1lisis longitudinal profundo de las vacunas contra la influenza de pr\u00f3xima generaci\u00f3n en adultos mayores (FluVax3)](https://ichgcp.net/es/clinical-trials-registry/NCT05518500)Envejecimiento | Vacuna contra la influenza | Respuesta a la vacuna | C\u00e9lula dendr\u00edtica\n-\nNCT05482282A\u00fan no reclutandoReacci\u00f3n adversa a la vacuna contra la difteria | Reacci\u00f3n adversa a la vacuna contra el t\u00e9tanos | Reacci\u00f3n adversa a la vacuna contra la tos ferina | Reacci\u00f3n adversa a la vacuna Haemophilus Influenzae tipo B | Reacci\u00f3n adversa a la vacuna contra la hepatitis B\n-\nNCT05298800ReclutamientoVacunas Antineumoc\u00f3cicas | La seguridad | Vacunas contra la influenza | Vacunas para COVID-19 | Inmunogenicidad, Vacuna\n-\nNCT05070494ReclutamientoESRD | Vacuna contra la influenza | Seroprotecci\u00f3n\n-\nNCT04579588ReclutamientoContagio de coronavirus | Inmunidad | Vacuna contra la gripe\n-\nNCT04355806A\u00fan no reclutando\n[Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors](https://ichgcp.net/es/clinical-trials-registry/NCT04355806)C\u00e1ncer de pulm\u00f3n de c\u00e9lulas no peque\u00f1as | Vacuna contra la influenza\n-\nNCT01997450Suspendido\n[Un estudio de casos y controles de la eficacia de Q/LAIV versus vacuna inactivada contra la influenza y ninguna vacuna en sujetos de 2 a 17 a\u00f1os de edad (ICICLE)](https://ichgcp.net/es/clinical-trials-registry/NCT01997450)Efectividad de la vacuna contra la influenza\n-\nNCT04785794Terminado\nEnsayos cl\u00ednicos sobre Tetravalente de dosis alta de Fluzone\n-\nNCT06029933ReclutamientoInfluenza | La comunidad adquiri\u00f3 neumon\u00eda | Eventos cardiovasculares\n-\nNCT05947071A\u00fan no reclutando\n[Vacuna contra la influenza de dosis alta versus dosis est\u00e1ndar en receptores pedi\u00e1tricos de SOT (PSOT)](https://ichgcp.net/es/clinical-trials-registry/NCT05947071)Influenza | Infecci\u00f3n de trasplante | Inmunizaci\u00f3n; Infecci\u00f3n\n-\nNCT05518500Reclutamiento\n[Un an\u00e1lisis longitudinal profundo de las vacunas contra la influenza de pr\u00f3xima generaci\u00f3n en adultos mayores (FluVax3)](https://ichgcp.net/es/clinical-trials-registry/NCT05518500)Envejecimiento | Vacuna contra la influenza | Respuesta a la vacuna | C\u00e9lula dendr\u00edtica\n-\nNCT05215327Reclutamiento\n[Vacuna contra la influenza de dosis alta versus dosis est\u00e1ndar en receptores de aloinjertos de pulm\u00f3n](https://ichgcp.net/es/clinical-trials-registry/NCT05215327)Influenza | Infecci\u00f3n de trasplante | Inmunizaci\u00f3n; Infecci\u00f3n\n-\nNCT04613206ReclutamientoInfluenza | Infecci\u00f3n de trasplante | Trasplante de \u00f3rganos s\u00f3lidos | Inmunizaci\u00f3n; Infecci\u00f3n\n-\nNCT04487041ReclutamientoGripe humana\n-\nNCT05426174Activo, no reclutando\n[Estudio de fase I, aleatorizado, modificado, doble ciego, de grupos paralelos, con control activo, de brazos m\u00faltiples y de escalado de dosis para evaluar la seguridad y la inmunogenicidad de la vacuna NA de ARNm monovalente en participantes adultos de 18 a\u00f1os de edad y mayores](https://ichgcp.net/es/clinical-trials-registry/NCT05426174)Influenza (Voluntarios Saludables)\n-\nNCT05553301Activo, no reclutando\n-\nNCT05650554Activo, no reclutando\n-\nNCT05007041TerminadoCalidad de vida | Dolor | Evento adverso de medicamentos | Reacci\u00f3n en el sitio de inyecci\u00f3n", "language": null, "image": null, "pagetype": "website", "links": ["https://ichgcp.net/es", "#", "https://ichgcp.net/de", "https://ichgcp.net/", "https://ichgcp.net/es", "https://ichgcp.net/fr", "https://ichgcp.net/it", "https://ichgcp.net/pt", "https://ichgcp.net/ru", "https://ichgcp.net/es/guidance-for-industry-investigator-responsibilities-protecting-the-rights-safety-and-welfare-of-study-subjects", "https://ichgcp.net/es/guidance-for-the-notification-of-serious-breaches-of-gcp-or-the-trial-protocol", "https://ichgcp.net/es/national-statement-on-ethical-conduct-in-human-research-2007-updated-2018-nhmrc-australia", "https://ichgcp.net/es/ministerial-ordinance-on-good-clinical-practice-for-drugs-pharmaceuticals-and-medical-devices-agency-japan", "https://ichgcp.net/es/ich-e-group-of-guidelines", "https://ichgcp.net/es/cro-list", "https://ichgcp.net/es/clinical-trials-registry", "https://ichgcp.net/es/eu-clinical-trials-registry", "https://ichgcp.net/es/pharma-list", "https://ichgcp.net/es/labs", "https://ichgcp.net/es/service-companies", "https://ichgcp.net/es/events", "https://ichgcp.net/es/clinical-trials-registry/publications", "https://ichgcp.net/es/clinical-trials-registry/researchers", "https://ichgcp.net/es/cra-jobs", "https://ichgcp.net/es/publications", "https://ichgcp.net/es/news", "https://ichgcp.net/clinical-trials-registry/NCT04077424", "https://telegram.me/share/url?url=https://ichgcp.net/es/clinical-trials-registry/NCT04077424&text=", "https://twitter.com/intent/tweet?url=https://ichgcp.net/es/clinical-trials-registry/NCT04077424", "https://ichgcp.net/es", "https://ichgcp.net/es/clinical-trials-registry", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Vanderbilt%20University%20Medical%20Center", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Flu%20Vaccine", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Fluzone-High%20Dose%20Quadrivalent", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Fluad", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Flublock", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Fluzone-High%20Dose%20Quadrivalent", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Fluad", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Flublock", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Vanderbilt%20University%20Medical%20Center", "https://ichgcp.net/es/clinical-trials-registry/research/list?term=adult%2065%20and%20older", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Physiological%20Effects%20of%20Drugs", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Immunologic%20Factors", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Agglutinins", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Vaccines", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Hemagglutinins", "https://clinicaltrials.gov", "mailto:register@clinicaltrials.gov", "https://clinicaltrials.gov", "https://ichgcp.net/es/clinical-trials-registry/NCT05996549", "https://ichgcp.net/es/clinical-trials-registry/NCT05869968", "https://ichgcp.net/es/clinical-trials-registry/NCT05518500", "https://ichgcp.net/es/clinical-trials-registry/NCT05482282", "https://ichgcp.net/es/clinical-trials-registry/NCT05298800", "https://ichgcp.net/es/clinical-trials-registry/NCT05070494", "https://ichgcp.net/es/clinical-trials-registry/NCT04579588", "https://ichgcp.net/es/clinical-trials-registry/NCT04355806", "https://ichgcp.net/es/clinical-trials-registry/NCT01997450", "https://ichgcp.net/es/clinical-trials-registry/NCT04785794", "https://ichgcp.net/es/clinical-trials-registry/NCT06029933", "https://ichgcp.net/es/clinical-trials-registry/NCT05947071", "https://ichgcp.net/es/clinical-trials-registry/NCT05518500", "https://ichgcp.net/es/clinical-trials-registry/NCT05215327", "https://ichgcp.net/es/clinical-trials-registry/NCT04613206", "https://ichgcp.net/es/clinical-trials-registry/NCT04487041", "https://ichgcp.net/es/clinical-trials-registry/NCT05426174", "https://ichgcp.net/es/clinical-trials-registry/NCT05553301", "https://ichgcp.net/es/clinical-trials-registry/NCT05650554", "https://ichgcp.net/es/clinical-trials-registry/NCT05007041", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Novartis%2BPharmaceuticals", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Center%2Bfor%2BIndustrial%2BTechnological%2BDevelopment%2Bof%2BSpain", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=GlaxoSmithKline", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Jos%25C3%25A9phine%2BSOLTANI%252C%2BCardiology%2Bdepartment%252C%2BVersailles%2BHospital", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=M.D.%2BAnderson%2BCancer%2BCenter", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Pfizer", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Universidade%2Bde%2BLisboa%252C%2BPortugal", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=National%2BCancer%2BInstitute%2B%2528NCI%2529", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Mayo%2BClinic", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=AstraZeneca", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Kaneka%2BAmericas%2BHolding%2BInc.", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Pediatric%2BOrthopaedic%2BSociety%2Bof%2BNorth%2BAmerica", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Universidad%2Bdel%2BZulia", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Assistance%2BPublique%2B-%2BH%25C3%25B4pitaux%2Bde%2BParis", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=European%2BSociety%2Bof%2BHuman%2BReproduction%2Band%2BEmbryology", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Orphanetics%2BPharma%2BEntwicklungs%2BGmbH", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=SeeCure%2BLLC", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Cairo%2BUniversity", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Assiut%2BUniversity", "https://ichgcp.net/es/clinical-trials-registry/research/list?spons=Medtronic%2BSurgical%2BTechnologies", "https://ichgcp.net/es/clinical-trials-registry/research/browse/spns_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Carcinoma%252C%2BAdrenal%2BCortical", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Ultrasound%2BEvaluation", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=HIV%2BInfections", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stage%2BI%2BGallbladder%2BCancer%2BAJCC%2Bv8", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Coronary%2BArtery%2BDisease", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Post-traumatic%2BAnosmia", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Colon%2BMalignant%2BTumor", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Pain", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Prostate%2BCancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Hypertension", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Esophageal%2BResection%2BCandidates", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Malignant%2BNeoplasm%2Bof%2BRespiratory%2Band%2BIntrathoracic%2BOrgan%2BCarcinoma", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Cushing%2527s%2BSyndrome%2BI", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Breast%2BCancer", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Depression", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Postneoadjuvant%2BTherapy%2BStage%2BI%2BGastric%2BCancer%2BAJCC%2Bv8", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Asthma", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Stroke", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Obesity", "https://ichgcp.net/es/clinical-trials-registry/research/list?cond=Ankle%2BArthroplasty", "https://ichgcp.net/es/clinical-trials-registry/research/browse/cond_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Cisplatin", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Dexamethasone", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Docetaxel", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Oral%2BGlucose%2BGel", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Bevacizumab", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Transplant%2B2%2BMelphalan", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Alpelisib%2B150%2BMG%2BOral%2BTablet%2B%255BPiqray%255D", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Valacyclovir%2Barrow", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=20mg%2BAzilsartan%2BTablets", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Gemcitabine", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Pilocarpine%2B1.25%2525%2BEye%2Bdrop", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Paclitaxel", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Prednisone", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=MK-8521%2B100%25CE%25BCg", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Brimonidine%2Btartrate%2Bophthalmic%2Bsolution%2B0.025%2525%2B%2528n%2B%253D%2B56%2529", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Teicoplanin%2BSandoz%2B200%2Bmg%2Bpowder%2Band%2Bsolvent%2Bfor%2Bsolution%2Bfor%2Binjection%2Bor%2Binfusion%2Bor%2Boral%2Bsolution.", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Injectafer", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Carboplatin", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Cyclophosphamide", "https://ichgcp.net/es/clinical-trials-registry/research/list?intr=Capecitabine", "https://ichgcp.net/es/clinical-trials-registry/research/browse/intr_alpha_all", "https://ichgcp.net/es/cro-list/country/belgium", "https://ichgcp.net/es/cro-list/country/canada", "https://ichgcp.net/es/cro-list/country/congo", "https://ichgcp.net/es/cro-list/country/czech_republic", "https://ichgcp.net/es/cro-list/country/gambia", "https://ichgcp.net/es/cro-list/country/ireland", "https://ichgcp.net/es/cro-list/country/luxembourg", "https://ichgcp.net/es/cro-list/country/mali", "https://ichgcp.net/es/cro-list/country/mauritius", "https://ichgcp.net/es/cro-list/country/norway", "https://ichgcp.net/es/cro-list/country/uganda", "https://ichgcp.net/es/cro-list/country/usa", "https://ichgcp.net/es/cro-list/country/uzbekistan", "https://ichgcp.net/es/cro-list", "https://ichgcp.net/es/cro-list/country/india/company/tcg_lifesciences_private_limited", "https://ichgcp.net/es/cro-list/country/india/company/rcc_laboratories", "https://ichgcp.net/es/cro-list/country/india/company/gct_global_clinical_trials", "https://ichgcp.net/es/cro-list/country/india/company/tech_observer", "https://ichgcp.net/es/cro-list/country/india/company/quest_diagnostics_inc", "https://ichgcp.net/es/cro-list/country/india/company/parexel", "https://ichgcp.net/es/cro-list/country/india/company/laxai", "https://ichgcp.net/es/cro-list/country/india/company/endpoint", "https://ichgcp.net/es/cro-list/country/india/company/take_solutions", "https://ichgcp.net/es/cro-list/country/india/company/icon", "https://ichgcp.net/es/cro-list/country/india", "https://ichgcp.net/es/clinical-trials-registry/research/browse/cond_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/cond_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/ord_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/intr_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/intr_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/diet_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/diet_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/spns_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/spns_cat", "https://ichgcp.net/es/clinical-trials-registry/research/browse/locn_alpha_all", "https://ichgcp.net/es/clinical-trials-registry/research/browse/locn_cat", "https://ichgcp.net/es", "https://ichgcp.net/es/guidance-for-industry-investigator-responsibilities-protecting-the-rights-safety-and-welfare-of-study-subjects", "https://ichgcp.net/es/guidance-for-the-notification-of-serious-breaches-of-gcp-or-the-trial-protocol", "https://ichgcp.net/es/national-statement-on-ethical-conduct-in-human-research-2007-updated-2018-nhmrc-australia", "https://ichgcp.net/es/ministerial-ordinance-on-good-clinical-practice-for-drugs-pharmaceuticals-and-medical-devices-agency-japan", "https://ichgcp.net/es/guideline-for-the-notification-of-serious-breaches-of-regulation-eu-no-536-2014", "https://ichgcp.net/es/cro-list", "https://ichgcp.net/es/pharma-list", "https://ichgcp.net/es/labs", "https://ichgcp.net/es/service-companies", "https://ichgcp.net/es/cra-jobs", "https://ichgcp.net/es/clinical-trials-registry", "https://ichgcp.net/es/eu-clinical-trials-registry", "https://ichgcp.net/es/publications", "https://ichgcp.net/es/news", "https://ichgcp.net/about-us-our-mission", "https://ichgcp.net/es/sitemap", "https://ichgcp.net/es/contact-us", "https://ichgcp.net/es/feed", "/privacy", "/disclaimer", "https://ichgcp.net/da/clinical-trials-registry/NCT04077424", "https://ichgcp.net/de/clinical-trials-registry/NCT04077424", "https://ichgcp.net/clinical-trials-registry/NCT04077424", "https://ichgcp.net/es/clinical-trials-registry/NCT04077424", "https://ichgcp.net/fr/clinical-trials-registry/NCT04077424", "https://ichgcp.net/it/clinical-trials-registry/NCT04077424", "https://ichgcp.net/hu/clinical-trials-registry/NCT04077424", "https://ichgcp.net/nl/clinical-trials-registry/NCT04077424", "https://ichgcp.net/no/clinical-trials-registry/NCT04077424", "https://ichgcp.net/pl/clinical-trials-registry/NCT04077424", "https://ichgcp.net/pt/clinical-trials-registry/NCT04077424", "https://ichgcp.net/fi/clinical-trials-registry/NCT04077424", "https://ichgcp.net/sv/clinical-trials-registry/NCT04077424", "https://ichgcp.net/cs/clinical-trials-registry/NCT04077424", "https://ichgcp.net/ru/clinical-trials-registry/NCT04077424", "https://ichgcp.net/ja/clinical-trials-registry/NCT04077424", "https://ichgcp.net/zh/clinical-trials-registry/NCT04077424", "https://ichgcp.net/ko/clinical-trials-registry/NCT04077424", "https://ichgcp.net/pdf/privacy_cookies_policy.pdf", "https://ichgcp.net/pdf/terms_of_service.pdf", "https://ichgcp.net/pdf/privacy_cookies_policy.pdf", "https://ichgcp.net/pdf/terms_of_service.pdf"]}